2 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
Follow Microsatellite Stable Rectal Carcinoma: new trials by email Literature Review of Microsatellite Stable Rectal Carcinoma trials Research Report on Microsatellite Stable Rectal Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer Botensilimab, Balstilimab - Early Rectal Cancer, Stage I Rectal Cancer | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 16 | 2026-08-10 | 2026-11-03 |
| A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma Balstilimab, Botensilimab - Microsatellite Stable Rectal Carcinoma, Locally Advanced Rectal Adenocarcinoma | Phase 2 | Recruiting | Memorial Sloan Kettering Cancer Center | 40 | 2025-02-20 | 2026-06-16 |
Rectal Neoplasms (1)
Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Rectal Diseases (1)
balstilimab (2)
Dana-Farber Cancer Institute (1) · Memorial Sloan Kettering Cancer Center (1)
United States (2)
Andrea Cercek, MD (1) · Benjamin Schlecher, MD (1)